ChinaBio Today -- October 18, 2008 -- Last week, at ChinaBio® Today, we discussed the implications of the new China offices of the US FDA; meanwhile, a China pharmaceutical product has once again caused deadly side effects; WuXi PharmaTech released weaker-than-expected financial Q3 results, while it also expanded one of its big pharma collaborations; China Aoxing Pharma said its 2008 revenues climbed 264%; China Biologic Products purchased a 35% stake in Xi'an Huitian Blood Products; Pioneer Surgical Technology signed up Bonovo Orthopedics. to distribute its products in China; Charles River Laboratories and Shanghai Explorer formally opened their preclinical facility in Shanghai; and China Sky One Medical said production started at a new subsidiary.
